[{"NetIncomeLoss_1_Q1_USD":-12280000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":2301000.0,"InterestPaidNet_1_Q1_USD":1195000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":841000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":150000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":3700000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":0.0,"Depreciation_1_Q1_USD":72000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":108403000.0,"IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_1_Q1_USD":2317000.0,"FinanceLeaseInterestPaymentOnLiability_1_Q1_USD":6000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":830000.0,"AssetsCurrent_0_Q1_USD":159353000.0,"OperatingLeaseExpense_1_Q1_USD":213000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":53000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":0.0,"SellingAndMarketingExpense_1_Q1_USD":5659000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":1632127.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":10000.0,"FinanceLeaseInterestExpense_1_Q1_USD":6000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":-128000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":815000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":14000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":98000.0,"CommonStockSharesIssued_0_Q1_shares":28741475.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":512000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":5915000.0,"Assets_0_Q1_USD":187140000.0,"PaidInKindInterest_1_Q1_USD":0.0,"AccountsAndOtherReceivablesNetCurrent_0_Q1_USD":12332000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":668000.0,"ClassOfWarrantOrRightOutstanding_0_Q1_shares":48683.0,"ResearchAndDevelopmentExpense_1_Q1_USD":5479000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":3508000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":43728000.0,"ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_0_Q1_USD":1965000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":18000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":1000.0,"CommonStockValue_0_Q1_USD":29000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":108769000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q1_USD":173000.0,"DeferredRevenueNoncurrent_0_Q1_USD":15349000.0,"IncreaseDecreaseInInventories_1_Q1_USD":248000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":75000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-12280000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":615000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":138579000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":2172000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":637797000.0,"Liabilities_0_Q1_USD":71433000.0,"FinanceLeaseLiability_0_Q1_USD":159000.0,"OperatingLeaseLiability_0_Q1_USD":2764000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5115000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":24735000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"ShareBasedCompensation_1_Q1_USD":988000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2484000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":128000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":988000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-15099000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":2773000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":849000.0,"LiabilitiesCurrent_0_Q1_USD":13441000.0,"DeferredRevenueCurrent_0_Q1_USD":973000.0,"AccountsPayableCurrent_0_Q1_USD":5855000.0,"NonoperatingIncomeExpense_1_Q1_USD":-1345000.0,"InterestExpense_1_Q1_USD":1346000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":138729000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2856000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":183000.0,"LongTermDebtNoncurrent_0_Q1_USD":38124000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1375000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":0.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q1_USD":32000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.125,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":0.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q1_USD":12.33,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":173000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":24594000.0,"OperatingLeasePayments_1_Q1_USD":221000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":559000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.125,"CommonStockSharesOutstanding_0_Q1_shares":28741475.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":93670000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-522960000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":108732000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":744000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":346000.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":7323000.0,"OperatingIncomeLoss_1_Q1_USD":-10935000.0,"InventoryNet_0_Q1_USD":5586000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":68322000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":187140000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2330000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-240000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"FinanceLeaseRightOfUseAsset_0_Q1_USD":155000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":592000.0,"OperatingExpenses_1_Q1_USD":18258000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-1798000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.5,"ProfitLoss_1_Q1_USD":-12280000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":2347000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":106000.0,"OtherLiabilitiesCurrent_0_Q1_USD":698000.0,"StockholdersEquity_0_Q1_USD":115707000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":0.0,"VariableLeaseCost_1_Q1_USD":9000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":988000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":685000.0,"Ticker":"EYPT","CIK":"1314102","name":"EYEPOINT PHARMACEUTICALS, INC.","OfficialName":"EyePoint Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"408871503.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210505"}]